Evidence map›Paper›PMID 31315929›Full record

ArticleThe Journal of biological chemistry2019

Human ATG4 autophagy proteases counteract attachment of ubiquitin-like LC3/GABARAP proteins to other cellular proteins.

Alexander Agrotis, Lucas von Chamier, Harriet Oliver, Koshiro Kiso, Tanya Singh, Robin Ketteler

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 1 synthesis or guideline pooled it, 66 citations in OpenAlex.

  1. Guideline
  2. Review
  3. Autophagy · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. ATG16L1 controls mammalian vacuolar proton ATPase.The Journal of cell biology · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. The Interplay between Autophagy and Mitochondria in Cancer.International journal of molecular sciences · 2024
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Alexander AgrotisMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.ORCID 0000-0002-4875-4499
Lucas von ChamierMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.
Harriet OliverMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.
Koshiro KisoMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.
Tanya SinghMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom.
Robin KettelerMRC Laboratory for Molecular Cell Biology, University College London, London WC1E 6BT, United Kingdom r.ketteler@ucl.ac.uk.
MRC Laboratory for Molecular Cell Biology · GB

Funding

Medical Research Council MC_EX_G0800785Medical Research Council MC_U12266BMedical Research Council MR/M02492X/1Wellcome TrustWellcome Trust 105604/Z/14/Z
6 · The paper itself

Abstract

Microtubule-associated protein 1 light chain 3 α (LC3)/GABA type A receptor-associated protein (GABARAP) comprises a family of ubiquitin-like proteins involved in (macro)autophagy, an important intracellular degradation pathway that delivers cytoplasmic material to lysosomes via double-membrane vesicles called autophagosomes. The only currently known cellular molecules covalently modified by LC3/GABARAP are membrane phospholipids such as phosphatidylethanolamine in the autophagosome membrane. Autophagy-related 4 cysteine peptidase (ATG4) proteases process inactive pro-LC3/GABARAP before lipidation, and the same proteases can also deconjugate LC3/GABARAP from lipids. To determine whether LC3/GABARAP has other molecular targets, here we generated a pre-processed LC3B mutant (Q116P) that is resistant to ATG4-mediated deconjugation. Upon expression in human cells and when assessed by immunoblotting under reducing and denaturing conditions, deconjugation-resistant LC3B accumulated in multiple forms and at much higher molecular weights than free LC3B. We observed a similar accumulation when pre-processed versions of all mammalian LC3/GABARAP isoforms were expressed in ATG4-deficient cell lines, suggesting that LC3/GABARAP can attach also to other larger molecules. We identified ATG3, the E2-like enzyme involved in LC3/GABARAP lipidation, as one target of conjugation with multiple copies of LC3/GABARAP. We show that LC3B-ATG3 conjugates are distinct from the LC3B-ATG3 thioester intermediate formed before lipidation, and we biochemically demonstrate that ATG4B can cleave LC3B-ATG3 conjugates. Finally, we determined ATG3 residue Lys-243 as an LC3B modification site. Overall, we provide the first cellular evidence that mammalian LC3/GABARAP post-translationally modifies proteins akin to ubiquitination ("LC3ylation"), with ATG4 proteases acting like deubiquitinating enzymes to counteract this modification ("deLC3ylation").

Indexed as

AutophagyApoptosis Regulatory ProteinsAutophagy-Related ProteinsCysteine EndopeptidasesHeLa CellsHumansMicrotubule-Associated ProteinsMolecular WeightMutationSubstrate SpecificityUbiquitinsApoptosis Regulatory ProteinsATG4B protein, humanAutophagy-Related ProteinsCysteine EndopeptidasesGABARAP protein, humanMAP1LC3A protein, humanMicrotubule-Associated ProteinsUbiquitinsATG4BAtg8autophagycysteine proteasedeconjugationdeubiquitylation (deubiquitination)GABARAPL2LC3ylationpost-translational modificationubiquitin-conjugating enzyme (E2 enzyme)

Identifiers

PMID31315929
PMCPMC6709618
OpenAlexW2963340250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.